Home › Immunoblastic Lymphadenopathy › Ohio
Immunoblastic Lymphadenopathy clinical trials in Ohio
4 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in Ohio.
Cities in Ohio
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- The Ohio State University, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06561048A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
- Clinical Trial Site, Cleveland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06393738Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- Miami Valley Hospital South, Centerville
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
- and 10 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04803201A Registry for People With T-cell Lymphoma
- Ohio State University (Data Collection Only), Columbus
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.